Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
| ▸ | CASR | P41180 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.36 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30471342 | 1.00 | GABRA1 (0.48) | GABRA1GABRB2TSHRACHECASR | |
| Ammonia Solution, Strong SCHEMBL782137 | 0.97 | GABRA1 (0.46) | GABRA1GABRB2TSHRACHECASR | |
| SCHEMBL15976427 | 0.90 | GABRA1 (0.48) | GABRA1GABRB2TSHRACHECASR | |
| Bicarbonate SCHEMBL16179256 | 0.87 | GABRA1 (0.39) | GABRA1GABRB2TSHRACHECASR | |
| SCHEMBL874172 | 0.84 | CASR (0.53) | GABRA1GABRB2TSHRACHECASR | |
| SCHEMBL2059781 | 0.83 | ALDH1A1 (0.50) | GABRA1GABRB2TSHRCASRALDH1A1 | |
| SCHEMBL29506834 | 0.83 | ALDH1A1 (0.50) | GABRA1GABRB2TSHRCASRALDH1A1 | |
| SCHEMBL10094721 | 0.81 | GABRA1 (0.42) | GABRA1GABRB2TSHRACHECASR | |
| SCHEMBL10437577 | 0.81 | ACHE (0.47) | GABRA1GABRB2TSHRACHECASR | |
| SCHEMBL8785533 | 0.81 | TSHR (0.47) | GABRA1GABRB2TSHRACHECASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116082208-B | Adsorption separation method of cymene oxidation product | 山东新和成精化科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-116082208-A | Adsorption separation method of cymene oxidation product | 山东新和成维生素有限公司 | 2023-05-09 | — | — | CN | claimed |
| US-11623975-B2 | Molding material and method for producing resin molded body using same | OSAKA UNIVERSITY (JP) | 2023-04-11 | — | — | US | claimed |
| CN-114976228-A | Ionic liquid gel polymer electrolyte suitable for large-scale positive electrode in-situ coating and preparation method and application thereof | 华南理工大学 | 2022-08-30 | — | — | CN | claimed |
| EP-3197510-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter & Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| WO-2016049458-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| CN-101638381-B | Synthesis method of montelukast sodium intermediate | LUNAN PHARM GROUP CORP | 2012-08-29 | — | — | CN | claimed |
| EP-1526124-B1 | Process for producing pyromellitic acid | MITSUBISHI GAS CHEMICAL CO (JP) | 2010-05-19 | — | — | EP | claimed |
| CN-101638381-A | Synthesis method of montelukast sodium intermediate | LUNAN PHARM GROUP CORP | 2010-02-03 | — | — | CN | claimed |
| US-7576170-B2 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS (US) | 2009-08-18 | — | — | US | claimed |
| US-7534912-B2 | catalytic oxidation of 2,4,5-trimethylbenzaldehyde; corrosion resistance; continuous, batch processing | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-05-19 | — | — | US | claimed |
| WO-2009053709-A1 | PROCESS FOR THE PREPARATION OF MEDETOMIDINE | NORBROOK LABORATORIES LIMITED (GB) | 2009-04-30 | — | — | WO | claimed |
| EP-1526124-A1 | Process for producing pyromellitic acid | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-04-27 | — | — | EP | claimed |
| US-20050085663-A1 | Process for producing pyromellitic acid | MITSUBISHI GAS CHEMICAL COMPANY, INC. | 2005-04-21 | — | — | US | claimed |
| EP-1425329-A1 | PROCESS FOR REDUCING RESIDUAL ISOCYANATE | 3M Innovative Properties Company (US) | 2004-06-09 | — | — | EP | claimed |
| US-6664414-B2 | Using quenching agents which is reaction product of phenolic alcohol and organosilicon compound | 3M INNOVATIVE PROPERTIES COMPANY | 2003-12-16 | — | — | US | claimed |
| US-20030092932-A1 | Process for reducing residual isocyanate | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-15 | — | — | US | claimed |
| WO-2003022901-A1 | PROCESS FOR REDUCING RESIDUAL ISOCYANATE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-03-20 | — | — | WO | claimed |
| EP-4688952-A1 | POLYMER COMPOSITION WITH FLAME AND ELECTRICAL TRACKING RESISTANCE | Celanese International Corporation (US) | 2026-02-11 | — | — | EP | disclosed |
| US-3931125-A | PROCESS FOR PRODUCING HYDROCARBON RESIN AND PRESSURE-SENSITIVE ADHESIVES CONTAINING SAME | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JA) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092932-A1 | Process for reducing residual isocyanate | ALKBH3, ALKBH2, TET2 | GABRA1 1716/4885GABRB2 1730/4885TSHR 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.